CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank54
3Y CAGR-55.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-55.1%/yr
vs +1.2%/yr prior
Acceleration
-56.3pp
Decelerating
Percentile
P54
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 2.90% |
| Q3 2025 | -0.99% |
| Q2 2025 | 0.55% |
| Q1 2025 | 6.66% |
| Q4 2024 | -3.83% |
| Q3 2024 | -6.74% |
| Q2 2024 | 1.65% |
| Q1 2024 | 4.46% |
| Q4 2023 | -9.22% |
| Q3 2023 | -391.75% |
| Q2 2023 | -58.90% |
| Q1 2023 | 56.56% |
| Q4 2022 | 31.92% |
| Q3 2022 | 42.81% |
| Q2 2022 | -111.25% |
| Q1 2022 | 32.63% |
| Q4 2021 | -557.21% |
| Q3 2021 | 18.86% |
| Q2 2021 | -325.61% |
| Q1 2021 | 98.56% |
| Q4 2020 | -220.11% |
| Q3 2020 | 36.94% |
| Q2 2020 | 60.26% |
| Q1 2020 | -524.27% |
| Q4 2019 | 13.20% |
| Q3 2019 | 30.71% |
| Q2 2019 | -143.10% |
| Q1 2019 | 2474.46% |
| Q4 2018 | -85.90% |
| Q3 2018 | 840.24% |
| Q2 2018 | -129.53% |
| Q1 2018 | -53.79% |
| Q4 2017 | 34.32% |
| Q3 2017 | 335.84% |
| Q2 2017 | 42.76% |
| Q1 2017 | -229.39% |
| Q4 2016 | -54.10% |
| Q3 2016 | 291.66% |
| Q2 2016 | -144.99% |
| Q1 2016 | -47.41% |